Kimberley Chiu1, Fan Zhang2, Siobhan Sutcliffe3, Indira U Mysorekar4, Jerry L Lowder1. 1. From the Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology. 2. Division of Clinical Research, Department of Obstetrics and Gynecology. 3. Division of Public Health Sciences, Department of Surgery, Washington University in St Louis, St Louis, MO. 4. Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX.
Abstract
OBJECTIVES: d-Mannose is a promising nonantibiotic prophylaxis for recurrent urinary tract infection (rUTI). Recurrent UTI is common in postmenopausal women and may be especially prevalent in those with cystitis cystica (CC) lesions found on cystoscopy. Our objectives were to determine whether CC lesions are associated with a higher UTI incidence rate and whether d-mannose reduces this rate in women with CC. METHODS: This is a retrospective cohort study of patients with rUTI who underwent cystoscopy at our institution (from which CC status was identified) and who were treated with d-mannose as a single agent for UTI prophylaxis. Participants were required to have at least 1 year of follow-up for UTIs both before and after d-mannose initiation to allow for a pre-post comparison. RESULTS: Twenty-seven patients were included in the analysis (13 with CC, 14 without CC). Most patients (88.9%) were postmenopausal. Patients with CC had a higher UTI incidence rate than patients without CC (4.69 vs 2.93 UTIs/year before starting d-mannose prophylaxis, P = 0.021). After initiating d-mannose prophylaxis, the UTI incidence rate decreased significantly in patients with CC (rate decrease = 2.23 UTIs/year, P = 0.0028). This decrease was similar in magnitude to that observed in patients without CC (rate decrease = 1.64 UTIs/year, P = 0.0007; P interaction = 0.58). CONCLUSIONS: Patients with rUTI with CC had more frequent UTI episodes than patients without CC. Patients in both groups had fewer UTI episodes after beginning d-mannose prophylaxis. These findings add to the body of literature supporting d-mannose for the prevention of rUTI in women, including those with CC.
OBJECTIVES: d-Mannose is a promising nonantibiotic prophylaxis for recurrent urinary tract infection (rUTI). Recurrent UTI is common in postmenopausal women and may be especially prevalent in those with cystitis cystica (CC) lesions found on cystoscopy. Our objectives were to determine whether CC lesions are associated with a higher UTI incidence rate and whether d-mannose reduces this rate in women with CC. METHODS: This is a retrospective cohort study of patients with rUTI who underwent cystoscopy at our institution (from which CC status was identified) and who were treated with d-mannose as a single agent for UTI prophylaxis. Participants were required to have at least 1 year of follow-up for UTIs both before and after d-mannose initiation to allow for a pre-post comparison. RESULTS: Twenty-seven patients were included in the analysis (13 with CC, 14 without CC). Most patients (88.9%) were postmenopausal. Patients with CC had a higher UTI incidence rate than patients without CC (4.69 vs 2.93 UTIs/year before starting d-mannose prophylaxis, P = 0.021). After initiating d-mannose prophylaxis, the UTI incidence rate decreased significantly in patients with CC (rate decrease = 2.23 UTIs/year, P = 0.0028). This decrease was similar in magnitude to that observed in patients without CC (rate decrease = 1.64 UTIs/year, P = 0.0007; P interaction = 0.58). CONCLUSIONS: Patients with rUTI with CC had more frequent UTI episodes than patients without CC. Patients in both groups had fewer UTI episodes after beginning d-mannose prophylaxis. These findings add to the body of literature supporting d-mannose for the prevention of rUTI in women, including those with CC.
Authors: Stacy M Lenger; Megan S Bradley; Debbie A Thomas; Marnie H Bertolet; Jerry L Lowder; Siobhan Sutcliffe Journal: Am J Obstet Gynecol Date: 2020-06-01 Impact factor: 8.661
Authors: Chia-Suei Hung; Julie Bouckaert; Danielle Hung; Jerome Pinkner; Charlotte Widberg; Anthony DeFusco; C Gale Auguste; Robert Strouse; Solomon Langermann; Gabriel Waksman; Scott J Hultgren Journal: Mol Microbiol Date: 2002-05 Impact factor: 3.501
Authors: Melanie R Meister; Caihong Wang; Jerry L Lowder; Indira U Mysorekar Journal: Female Pelvic Med Reconstr Surg Date: 2021-01-01 Impact factor: 1.913
Authors: Marianne M Ligon; Caihong Wang; Erica N DeJong; Christian Schulz; Dawn M E Bowdish; Indira U Mysorekar Journal: Mucosal Immunol Date: 2020-05-04 Impact factor: 7.313